|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Lymphocyte responses following open and minimally invasive thoracic surgery显示文摘 | Leaver RE Craig SR Yap PL | 2000 | Eur J Clin Invest2000，30，： | 1 |
| 2 | Lymphocyte response following open and minimally invasive thoracic surgery 显示文摘 | Leaver HA Craig SR Yap PL | 2000 | Eur J Clin Invest2000，30，： | 1 |
| 3 | Detection of parvovirus B19-in donated blood: a model system for screening by polymerase chain reaction 显示文摘 | Mcomish F Yap PL Jordan A | 1993 | J Clin Microbiol1993，31，2： | 1 |
| 4 | Sequence variabilityin the 5'non-coding region of hepatitis C virus:identification ofa new virus type and restrictions on sequence diversity显示文摘 | Simmonds P McOmish F Yap PL | 1993 | J GenVirol1993，74，： | 1 |
| 5 | Lymphocyte response fol- lowing open and minimally invasive thoracic surgery 显示文摘 | Leaver HA Craiq SR Yap PL | 2000 | Eur J Clin Invest2000，30，3： | 1 |
| 6 | 静脉注射用免疫球蛋白在继发性免疫缺陷症中的应用显示文摘在癌症、烧伤、外伤、病毒感染或化疗所致的免疫缺损病人中,细菌和病毒感染是致病和致死的重要因素.适合静脉输注的安全有效抗体制剂的开发,业已使那些以抗体缺乏为特征的原发性免疫缺陷症病人的生活发生了变化.然而静脉注射用免疫球蛋白制剂(IVIG)治疗继发性免疫缺陷症的作用却并不太清楚.尽管已有不少关于IVIG治疗各种继发性免疫缺陷症的报道,但缺乏足够规模的对照试验以证明其明显效力.本文综述了IVIG在继发性免疫缺陷症中的应用情况. | Yap PL 陈国兴 | 1990 | 国外医学(预防.诊断.治疗用生物制品分册)1990，13，5： | 1 |
| 7 | Acute phase responses fol- lowing minimal access and conventional thoracic surgery显示文摘 | Craiq SR Leaver HA Yap PL | 2001 | Eur J Cardiothorac Surq2001，20，3： | 1 |
| 8 | Acute phase re-sponses following minimal access and conventional thoracic surgery显示文摘 | Craig SR Leaver HA Yap PL | | 0，，03： | 1 |
| 9 | Sequence variability in the 5' non- coding region of hepatitis C virus identification of new virus type and restriction on sequence diversity 显示文摘 | Simmonds P McOmish F Yap PL | 1993 | J Gen Virol1993，74，66： | 1 |
| 10 | Acute phase responses following minimal access and conventional thoracic surgery显示文摘 | Craig SR Leaver HA Yap PL | 2001 | Eur J Cardiothorac Surg2001，20，： | 1 |
| 11 | Acute phase responses following minimal access and conventional thoracic surgery显示文摘 | Craig SR Leaver HA Yap PL | 2001 | Eur J Cardiothorac Surg2001，20，3： | 1 |
| 12 | Acute phase responses following minimal access and conventional thoracic surgery显示文摘 | Craig SR Leaver HA Yap PL | 2001 | Eur J CardiothoracSurg2001，20，： | 1 |
| 13 | Lymphocyte responses follow- ing open and minimally invasive thoracic surgery显示文摘 | Leaver HA Craig SR Yap PL | 2000 | EurJ Clin In- vest2000，30，： | 1 |
| 14 | 静注免疫球蛋白治疗继发性免疫缺陷病显示文摘静注免疫球蛋白(IVIgG)治疗各种继发性免疫缺陷,需认真分析免疫缺陷的基本性质。若不缺乏特异性抗体,则IVIgG治疗未必有效。目前IVIgG的治疗计划多着眼于IVIgG的总量,而特异性抗体的量、特异性抗体在体内达到的水平及用后在循环中维持的时间也不容忽视。继发性免疫缺陷患者特异性抗体的半寿期依血清IVIgG的浓度而定,烧伤患者的抗体通过烧伤的组织迅速大量丧失,骨髓移植后患者呈高分解状态,多发性骨髓瘤(MM)因存在高丙种球蛋白血症而使IgG抗体分解代谢亢进,故继发性免疫缺陷患者所需的IVIgG剂量各不相同。 | Yap PL 张延年 | 1991 | 国外医学(输血及血液学分册)1991，14，2： | 1 |
| 15 | Sequence variability in the 5' non-coding region of hepatitis C virus identification of new vires type and restriction on sequence diversity 显示文摘 | Simmonds P McOmish F Yap PL | 1993 | J Gen Virol1993，74，4： | 1 |
| 16 | Geographical distribution of hepatitis C Virus genotypes in blood donors:an international collaborative survey 显示文摘 | MCOMISH F YAP PL DOW BC | 1994 | J Clin Microbiol1994，32，4： | 1 |
| 17 | Acute phase responses following minimal access and conventional thoracic surgery显示文摘 | Craig SR Leaver HA Yap PL | 2001 | Eur J Cardiothoracic Surg2001，20，3： | 1 |
| 18 | Lymphocyte responses following open and minimally invasive thoracic surgery显示文摘 | Leaver HA Craig SR Yap PL | 2000 | Eur J Clin Invest2000，30，2： | 1 |
| 19 | Lymphocyte responses following open and minimally invasive thoracic surgery显示文摘 | Leaver RE Craig SR Yap PL | 2000 | Eur J Clin Invest2000，30，3： | 1 |
| 20 | Sequence variability in the 5' - non - coding region of hepatitis C virus : identification of a new virus type andrestrictions on sequence diversity 显示文摘 | P Simmonds F McOmish PL Yap | 1993 | J General Virol1993，74，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员